TCL Archive DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting March 12, 1982
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard February 22, 2013
